Revuforj Tablet, Film Coated
Product Images NDC 73555-502

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Revuforj (NDC 73555-502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Syndax Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure Of Revumenib Citrate (Chemical Structure Of Revumenib Citrate)

Chemical structure of revumenib, the active ingredient in Revuforj, shown with associated molecular groups including a fluorophenyl and piperazine ring system, as well as representations of tartaric acid and water.*

FDA Label Image

Figure A (Figure A)

An instructional illustration showing five objects for medication preparation or administration: a 20 mL oral syringe labeled with barrel and plunger, a pill crusher with labeled cap and bottom parts, a glass of room temperature water with bubbles, a teaspoon, and a small plastic or glass cup. The illustration is labeled to identify each item precisely.*

FDA Label Image

Figure B (Figure B)

An illustration diagram showing a two-part closure system of a container. The cap is depicted above, labeled separately from the container bottom, which contains granules or small particles. Each part is clearly labeled 'cap' and 'bottom' to indicate assembly components.*

FDA Label Image

Figure C (Figure C)

An instructional illustration showing a hand holding a spoon from which liquid droplets are falling into a cup below. The image indicates a step in dosage or medication administration involving liquid drops being added to a cup.*

FDA Label Image

Figure D (Figure D)

An instructional illustration showing a hand pouring small granules or powder from a bottle into a cup. The image is likely demonstrating how to administer or prepare an oral dosage form, such as a tablet or granules for oral intake.*

FDA Label Image

Figure E (Figure E)

An instructional illustration showing a hand holding a container with liquid being gently inverted and shaken. Next to it is a clock face indicating 5 minutes, suggesting the shaking duration.*

FDA Label Image

Figure F (Figure F)

An instructional illustration showing a hand holding a syringe with labeled parts: plunger and barrel. The syringe tip is submerged in a container of liquid, and an upward arrow indicates the motion of pulling the plunger back.*

FDA Label Image

Figure G (Figure G)

An instructional line drawing illustrating the oral administration of medication using a syringe. The image labels the syringe components 'plunger' and 'barrel' and depicts the syringe being placed into a person's open mouth for dosing.*

FDA Label Image

Figure H (Figure H)

An instructional line drawing showing a hand holding a spoon above a glass of liquid with drops falling from the spoon into the glass. The image likely depicts how to administer or measure a liquid dose, though no specific product information is visible.*

FDA Label Image

Figure I (Figure I)

An instructional illustration showing a hand holding a pill bottle and twisting the cap in a counterclockwise direction, indicating how to open the bottle.*

FDA Label Image

Figure J (Figure J)

An instructional illustration showing how to separate the barrel and plunger components of a device or syringe by pulling them apart in opposite directions, indicated by arrows pointing away from each other.*

FDA Label Image

Figure K (Figure K)

An instructional diagram showing a hand holding a syringe barrel under a faucet with water flowing onto it. The plunger of the syringe is detached and shown on the right side with drops falling from it. The barrel and plunger components of the syringe are labeled.*

FDA Label Image

Figure L (Figure L)

An instructional diagram showing two positions of a syringe with labeled parts: the barrel and the plunger. The first image shows the plunger being pulled back, indicated by an arrow pointing left. The second image shows the syringe with the plunger pushed forward.*

FDA Label Image

Figure M (Figure M)

An instructional illustration showing a two-step process using a syringe and a bowl. Step one shows a hand pulling the syringe plunger upwards, and step two shows a hand pressing the plunger down to dispense liquid into the bowl. No text or brand information is visible.*

FDA Label Image

Figure N (Figure N)

An instructional diagram showing a hand holding a syringe barrel under running water from a faucet. Drops are falling from the syringe. The plunger of the syringe is shown separately with water dripping from it. The parts labeled include the barrel and the plunger.*

FDA Label Image

Figure O (Figure O)

An instructional illustration showing a hand holding a syringe barrel, with arrows indicating the barrel being pulled back and pushed forward to dispense liquid drops. The separate plunger component of the syringe is labeled and displayed to the right of the hand.*

FDA Label Image

Revuforj 110 mg Carton (Revuforj 110 mg Carton)

Packaging label for Revuforj 110 mg film-coated tablets containing revumenib. The label shows a 30-tablet carton distributed by Syndax Pharmaceuticals, Inc. It includes dosage strength, tablet use instructions, storage conditions, and a barcode. The design features brown and white coloring with the brand logo and medication guide information.*

FDA Label Image

Revuforj 110 mg Container (Revuforj 110 mg Container)

Label for Revuforj 110 mg film-coated tablets, containing 30 tablets per bottle. The active ingredient is revumenib. The label includes usage instructions, storage conditions, and manufacturer information, showing Syndax Pharmaceuticals, Inc. It is an oral prescription drug with a barcode and NDC placeholder on the right side.*

FDA Label Image

Revuforj 160 mg Carton (Revuforj 160 mg Carton)

Packaging label for Revuforj 160 mg film-coated oral tablets by Syndax Pharmaceuticals, Inc. The label includes the product name, generic name revumenib, strength, and quantity of 30 tablets. It features instructions to swallow whole or disperse in water, contact information, storage conditions, and a barcode.*

FDA Label Image

Revuforj 160 mg Container (Revuforj 160 mg Container)

Revuforj 160 mg film-coated tablets label from Syndax Pharmaceuticals, Inc. The label specifies the product contains 30 tablets of 160 mg revumenib each. It includes storage instructions and usage directions advising tablets to be swallowed whole or crushed and dispersed in water.*

FDA Label Image

Revuforj 25 mg Carton (Revuforj 25 mg Carton)

Carton packaging label for Revuforj 25 mg film-coated tablets containing revumenib. The label states it contains 30 tablets and is distributed by Syndax Pharmaceuticals, Inc. Instructions note swallowing whole or dispersing in water and emphasize dispensing a Medication Guide with each patient. The design includes the proprietary name, generic name, dosage strength, NDC placeholder, and storage instructions with a barcode.*

FDA Label Image

Revuforj 25 mg Container (Revuforj 25 mg Container)

Revuforj 25 mg film-coated tablets packaging label displaying a white rectangular box with dosage instructions and warnings. The label includes the brand and generic name revumenib, medication strength (25 mg), a 30-tablet count, and highlights that it is for oral administration. Manufacturer Syndax Pharmaceuticals, Inc. is noted along with storage instructions and a caution to keep out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.